Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Merrick

Showing results (171-180 of 261) with videos related to

Pageof 27
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Long-term outcome for clinically localized prostate cancer treated with permanent interstitial brachytherapyAl V Taira, Gregory S Merrick, Wayne M Butler, et al.
BJU International|August 2, 2006
Brachytherapy in men aged < or = 54 years with clinically localized prostate cancerGregory S Merrick, Kent E Wallner, Wayne M Butler, et al.
Urology|December 20, 2005
Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancerMark A Moyad, Gregory S Merrick, Wayne M Butler, et al.
Urologic Oncology|December 1, 2009
Obesity does not correlate with adverse pathologic findings on transperineal template-guided mapping biopsy of the prostateNathan Bittner, Gregory S Merrick, Renee Stewart, et al.
Brachytherapy|January 23, 2017
The American College of Radiology and the American Brachytherapy Society practice parameter for transperineal permanent brachytherapy of prostate cancerNathan H J Bittner, Peter F Orio, Gregory S Merrick, et al.
Cancer Journal (Sudbury, Mass.)|May 4, 2007
Long-term rectal function after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Cancer|June 6, 2007
Primary Gleason pattern does not impact survival after permanent interstitial brachytherapy for Gleason score 7 prostate cancerGregory S Merrick, Robert W Galbreath, Wayne M Butler, et al.
Brachytherapy|April 28, 2004
The effect of hormonal manipulation on urinary function following permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|August 5, 2008
Influence of Pro-Qura-generated plans on postimplant dosimetric quality: a review of a multi-institutional databaseZachariah Allen, Gregory S Merrick, Peter Grimm, et al.
International Journal of Radiation Oncology, Biology, Physics|February 10, 2007
Androgen deprivation therapy does not impact cause-specific or overall survival in high-risk prostate cancer managed with brachytherapy and supplemental external beamGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Pageof 27

Showing results (171-180 of 261) with videos related to

Sort By:
Pageof 27
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Long-term outcome for clinically localized prostate cancer treated with permanent interstitial brachytherapyAl V Taira, Gregory S Merrick, Wayne M Butler, et al.
BJU International|August 2, 2006
Brachytherapy in men aged < or = 54 years with clinically localized prostate cancerGregory S Merrick, Kent E Wallner, Wayne M Butler, et al.
Urology|December 20, 2005
Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancerMark A Moyad, Gregory S Merrick, Wayne M Butler, et al.
Urologic Oncology|December 1, 2009
Obesity does not correlate with adverse pathologic findings on transperineal template-guided mapping biopsy of the prostateNathan Bittner, Gregory S Merrick, Renee Stewart, et al.
Brachytherapy|January 23, 2017
The American College of Radiology and the American Brachytherapy Society practice parameter for transperineal permanent brachytherapy of prostate cancerNathan H J Bittner, Peter F Orio, Gregory S Merrick, et al.
Cancer Journal (Sudbury, Mass.)|May 4, 2007
Long-term rectal function after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Cancer|June 6, 2007
Primary Gleason pattern does not impact survival after permanent interstitial brachytherapy for Gleason score 7 prostate cancerGregory S Merrick, Robert W Galbreath, Wayne M Butler, et al.
Brachytherapy|April 28, 2004
The effect of hormonal manipulation on urinary function following permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|August 5, 2008
Influence of Pro-Qura-generated plans on postimplant dosimetric quality: a review of a multi-institutional databaseZachariah Allen, Gregory S Merrick, Peter Grimm, et al.
International Journal of Radiation Oncology, Biology, Physics|February 10, 2007
Androgen deprivation therapy does not impact cause-specific or overall survival in high-risk prostate cancer managed with brachytherapy and supplemental external beamGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Pageof 27